OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Drug Processing


As per available reports about 101 relevant journals, 28 Conferences, 28workshops are presently dedicated exclusively to Drug processing and about 5000articles are being published on Drug processing.

Drug Processing is a combination of drug discovery, drug development, clinical trials, drug manufacturing. Drug discovery: With a very changes in their chemical structure or nomenclature a new molecule may discovered. Drug development is a blanket term used to define the process of bringing a new drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research (microorganisms/animals) and clinical trials (on humans) and may include the step of obtaining regulatory approval to market the drug. It is enlisted in Computer Aided Drug Design-CADD, Advanced Medicinal Chemistry, Drug Design and Chemistry.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance:

On average about 250 of these will show sufficient promise for further evaluation using laboratory tests, mice and other test animals. Typically, about ten of these will qualify for tests on humans. A study conducted by the Tufts Center for the Study of Drug Development covering the 1980s and 1990s found that only 21.5 percent of drugs that start phase I trials are eventually approved for marketing. The high failure rates associated with pharmaceutical development are referred to as the "attrition rate" problem. Careful decision making during drug development is essential to avoid costly failures. In many cases, intelligent programme and clinical trial design can prevent false negative results. Well-designed dose-finding studies and comparisons against both a placebo and a gold-standard treatment arm play a major role in achieving reliable data.

Drug Processing is a combination of drug discovery, drug development, clinical trials, drug manufacturing.

Drug discovery:

With a very changes in their chemical structure or nomenclature a new molecule may discovered.

Drug development is a blanket term used to define the process of bringing a new drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research (microorganisms/animals) and clinical trials (on humans) and may include the step of obtaining regulatory approval to market the drug.

Clinical Trials involves three or four steps:

Phase I trials, usually in healthy volunteers, determine safety and dosing.

Phase II trials are used to get an initial reading of efficacy and further explore safety in small numbers of sick patients.

Phase III trials are large, pivotal trials to determine safety and efficacy in sufficiently large numbers of patients.

 (Phase 4): These are post-approval trials that are sometimes a condition attached by the FDA, also called post-market surveillance studies.

Success Rate:

Candidates for a new drug to treat a disease might theoretically include from 5,000 to 10,000 chemical compounds. On average about 250 of these will show sufficient promise for further evaluation using laboratory tests, mice and other test animals. Typically, about ten of these will qualify for tests on humans. A study conducted by the Tufts Center for the Study of Drug Development covering the 1980s and 1990s found that only 21.5 percent of drugs that start phase I trials are eventually approved for marketing. The high failure rates associated with pharmaceutical development are referred to as the "attrition rate" problem. Careful decision making during drug development is essential to avoid costly failures. In many cases, intelligent programme and clinical trial design can prevent false negative results. Well-designed dose-finding studies and comparisons against both a placebo and a gold-standard treatment arm play a major role in achieving reliable data

Drug Manufacturing:

It is the process of industrial- scale synthesis of Pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be broken down into a series of unit operations, such as milling, Granulation, Coating, Compression, and others.

Market Analysis:

The global market for organic light emitting diodes (OLED) was about $2.1 billion and $2.5 billion in 2013 and 2014, respectively. This market is expected to reach nearly $3.1 billion in 2015 and $9.6 billion in 2020, registering a compound annual growth rate (CAGR) of 25.7% for the period 2015-2020.

International Symposium and Workshops

  1. 17th International Conference on Drug Processing, Labelling and Packaging, Venice, Italy, August 13 - 14, 2015
  2. 4th International Summit on GMP, GCP & Quality Control October 26-28, 2015 Hyderabad, India
  3.  First International Prescription Drug Labelling Conference, Horsham, PA, USA — Oct 26, 2015

List of Best International Conferences:

  1. Industrial Pharmacy Conference April 11-12, 2016 Dubai, UAE
  2. Drug Formulation and Bioavailability Congress June 6-8, 2016 Beijing, China
  3. 4th Pharma Congress June 13-15, 2016 Berlin, Germany
  4. Pharma Expo June 20-22,2016 New Orleans, USA
  5. 7th Pharma Conference June 20-22, 2016 New Orleans, USA
  6. Pharmaceutical Conference and Expo October 08-10, 2015 New Delhi, India
  7. Pharma Expo July 14-16, 2016 Kualalumpur, Malaysia
  8. 6th Pharma Congress July 14-16, 2016 Kualalumpur, Malaysia
  9. Pharma Expo August 29-31, 2016 Sao Paulo, Brazil
  10. 2nd Pharma Middle East Congress October 12-14, 2016 Dubai, UAE
  11. Pharma Marketing Conference November 17-19, 2016 Alicante, Spain
  12. 2nd Parenterals and Injectables Conference October 24-26, 2016 Istanbul, Turkey
  13. 5th Pharmacists Annual Meeting July 11-13, 2016 Brisbane, Australia
  14. 4th GMPGCP and Quality Control Conference October 26-28, 2015 Hyderabad, India
  15. Pharmaceutical Packaging and Labelling Summit, 22 - 23 June, 2016 - UK
  16. 2nd Annual Medical Device and Diagnostic Labeling Conference, 9th – 10th September, 2015, Berlin, Germany
  17. Pharma Packaging and Labeling, 24th – 25th February 2016, Philadelphia, USA
  18. Pharma Packaging and Labeling, 24th – 25th February 2016, Philadelphia, USA
  19. Global Packaging Summit January 25-26, 2016, Belgium
  20. American Packaging Summit April 18-19, 2016, Chicago
  21. Label Expo, EUROPE 2015, 29 September - 2 October
  22. Label Expo, ASIA 1 - 4 December, 2015 China
  23. Label Summit 26 - 27 April, 2015, Las Vegas, USA
  24. Label Expo, 13 - 15 September, 2016, Chicago, USA
  25. Label Expo, 17 - 20 November, Noida, India
  26. PhillyPack, October 7-8, 2015, Philadelphia, PA
  27. TexasPack, October 13-14, 2015, Houston, TX
  28. Drug Discovery & Therapy World Congress 2015

Relevant Society and Associations 

Companies

This page will be updated regularly.

This page was last updated on 14th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising